key: cord-0845295-ye9zjcak authors: Amaku, M.; Covas, D. T.; Coutinho, F. A. B.; Azevedo, R. S.; Struchiner, C.; Wilder-Smith, A.; Massad, E. title: Modelling the Test, Trace and Quarantine Strategy to Control the COVID-19 Epidemic in the State of Sao Paulo, Brazil date: 2020-12-04 journal: nan DOI: 10.1101/2020.12.02.20242743 sha: ca2cc5157776c5c5198139cbadbaaaea03e2a8a2 doc_id: 845295 cord_uid: ye9zjcak Testing for detecting the infection by SARS-CoV-2 is the bridge between the lockdown and the opening of society. In this paper we modelled and simulated a test-trace-and-quarantine strategy to control the COVID-19 outbreak in the State of Sao Paulo, Brasil. The State of Sao Paulo failed to adopt an effective social distancing strategy, reaching at most 59% in late March and started to relax the measures in late June, dropping to 41% in 08 August. Therefore, Sao Paulo relies heavily on a massive testing strategy in the attempt to control the epidemic. Two alternative strategies combined with economic evaluations were simulated. One strategy included indiscriminately testing the entire population of the State, reaching more than 40 million people at a maximum cost of 2.25 billion USD, that would reduce the total number of cases by the end of 2020 by 90%. The second strategy investigated testing only symptomatic cases and their immediate contacts - this strategy reached a maximum cost of 150 million USD but also reduced the number of cases by 90%. The conclusion is that if the State of Sao Paulo had decided to adopt the simulated strategy on April the 1st, it would have been possible to reduce the total number of cases by 90% at a cost of 2.25 billion US dollars for the indiscriminate strategy but at a much smaller cost of 125 million US dollars for the selective testing of symptomatic cases and their contacts. Despite lockdowns in China, SARS-CoV-2 spread rapidly throughout the world by predicted routes of transportation (Bogoch et al., 2020) and spread faster than any other emerging infectious disease in recent decades (Angelo et al., 2019; Halstead & Wilder-Smith, 2019; Tuite et al., 2019; Wilder-Smith, Chang, & Leong, 2019) . The first case of COVID-19 in Latin America was confirmed on 26 February 2020, in the São Paulo metropolis, the most populous city in the Southern hemisphere (~12 million people) (Instituto Brasileiro de Geografia e Estatística, 2020). Travel reports and subsequent genetic analyses confirmed that the first detected infection was acquired via importation of the virus from Northern Italy Jesus et al., 2020) . Since then, Brazil has reported the largest number of cases in Latin America (4, 238, 446 reported cases and 129,522 deaths as of 11 September 2020) (Ministério da Saúde do Brasil, 2020) . SARS-CoV-2 spread rapidly within Brazil , often associated with urban centers with social deprivation and has now been detected in the majority of the 27 federal states of Brazil. Using transmission pairs of SARS-CoV-2 reported to the Brazilian Ministry of Health, the mean and standard deviation for the serial interval was estimated to be 2.97 and 3.29 days respectively (Prete et al., 2020) . Social distancing, stay-at-home policies and discontinuation of mass gatherings up to complete lockdowns are important tenets of public health measures to mitigate the explosive growth of COVID-19 (Wilder-Smith & Freedman, 2020) . However, the most effective public health measures include liberal testing, prompt isolation of all test 3 positive persons, contact tracing of all test positive cases and enforced quarantining of all contacts (Hellewell et al., 2020; Salathe et al., 2020) . Here we set out to model the number of infections and deaths depending on the timing and extent of testing and contact tracing in the State of Sao Paulo, the most populous state of Brazil with 44,639,899 inhabitants (Biblioteca Virtual do Estado de São Paulo, 2020) . The model is a modified version of the classical SEIR type of models (Massad et al., 2020) and considers that the population is divided into several compartments, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint 5 Figure 1 -Schematic representation of the model compartments. The model's dynamics is described by the following set of differential equations: . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint The Basic Reproduction Number of system (1) is given by: The incidence of infection is given by: . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101 /2020.12.02.20242743 doi: medRxiv preprint 7 The total number of reported cases is obtained by multiplying the number of infected individuals by a notification ratio The total number of COVID-19-related deaths is given by: Finally, the total number of tested individuals is given by: Data on the cumulative number of reported cases and deaths were obtained from Seade (Fundação Sistema Estadual de Análise de Dados do Estado de São Paulo). Data on the number of ICU patients were obtained from SIMI (Sistema de Monitoramento Inteligente do Estado de São Paulo). A fitting procedure based on the Levenberg-Marquardt non-linear least-squares algorithm was used to fit the model's parameters simultaneously to the data on cases, deaths and ICU patients. We used the R package minpack.lm (Elzhov et al., 2016) . We assumed that the potentially infective contact rate, the notification ratio, and the ICU admission rate change every 10 days. (As it will be explained in another paper this simulates the propagation of the disease and compliance with social distancing rules). The parameter values used are shown in Table 1 . Model projections for future dates were obtained by keeping fixed the fitted values of the parameters from the last date observed in the data. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. The cost of the strategy was calculated assuming the cost of the test, assumed the price tag of US$48.00 per sample and the cost of the agenst salary, assumed to be US$1,128.00 per month. The total cost of each simulated strategy would depend on the rate and of the total number of testing, as well as the duration of each strategy. We fitted the model's parameters simultaneously to the data of cumulative number of reported cases and deaths (Figures 2(a) and 2(b), respectively), and the number of ICU patients for the state of São Paulo until July 18, 2020. To estimate a 95% probability interval (shaded area in Figure 2 ), we assumed a normal distribution for the contact rate with a standard deviation of 1.5%. The fitted parameters are shown in Table 1 . The results for the strategy that considers testing susceptible and infected (symptomatic and asymptomatic) individuals are shown in Figure 3 . We calculated a testing strategy efficacy, subtracting from 1 the result of the division of the number of cumulative cases under a specific testing strategy up to December 31, 2020 by the number of reported cases in a scenario in which no test is used. The testing strategy efficacies as a function of the total number of tests and corresponding costs in US dollars are shown in Figures 3(a) and 3(b) , respectively, for different times ti, the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 10 strategy started to be applied. We noticed that a 50% reduction in the number of cases is only achieved when the total number of tests is approximately 40 million (the state population is about 44.6 million people) with an approximate total cost of 2 billion US dollars, except for the start date of August 1 st . The results for the strategy that considers testing infected (symptomatic and asymptomatic/oligosymptomatic) individuals are shown in Figure 4 . The testing strategy efficacies as a function of the total number of tests and corresponding costs in US dollars are shown in Figures 4(a) and 4(b) , respectively, for different dates of start. In Figures 3 and 4 , each dot corresponds to a different daily testing rate and the dot size is proportional to the testing rate. Dot sizes and corresponding testing rates can be observed in Figure 5 , in which we observe that higher testing rates and earlier start dates are more efficacious. In Figure 4 (a), dots in the upper part of the graph correspond to higher testing rates. For each date of start, we noticed that dots corresponding to different testing rates are displayed in a concave shape. Thus, depending on the testing rate, similar total number of tests may result in different efficacies. Let us consider the specific case of the testing rates 0.5% and 2.1% per day for the start date of April 1 st (Figure 6 ). We noticed in Figure 4 When only (suspected) infected individuals are tested, the total cost is higher for earlier start dates (Figure 4(b) ), because operational costs are substantionally higher than the costs related to the diagnostic tests. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint Figure 3 -Results for the strategy that considers testing susceptible and infected (symptomatic and asymptomatic) individuals showing the evolution of the testing strategy efficacy (1 minus the number of cumulative cases under a specific testing strategy up to December 31, 2020 divided by the number of cases when no test is used) as a function of the total number of tests (a) and corresponding costs in US dollars (b) for different dates of start. Each dot corresponds to a different daily testing rate and the dot size is proportional to the testing rate. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 13 Figure 4 -Results for the strategy that considers testing infected (symptomatic and asymptomatic) individuals showing the evolution of the testing strategy efficacy (1 minus the number of cumulative cases under a specific testing strategy up to December 31, 2020 divided by the number of cases when no test is used) as a function of the total number of tests (a) and corresponding costs in US dollars (b) for different dates of start. Each dot corresponds to a different daily testing rate and the dot size is proportional to the testing rate. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 14 Figure 5 -Results for the strategy that considers testing infected (symptomatic and asymptomatic) individuals showing the evolution of the testing strategy efficacy (1 minus the number of cumulative cases under a specific testing strategy up to December 31, 2020 divided by the number of cases when no test is used) as a function of the daily testing rate for different dates of start. The dot size is proportional to the testing rate. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint Figure 6 -Total number of tests over time and the corresponding number of cumulative cases for two different daily testing rates (0.5% and 2.1% per day) for mass testing starting on April 1 st . We modelled and simulated a test-trace-and-quarantine strategy to control the COVID-19 outbreak in the State of São Paulo, Brasil. The State of São Paulo failed to adopt an effective social distancing strategy, reaching at most 59% in late March and started to relax the measures in late June, dropping to 42% in 11 September (Sistema de Monitoramento Inteligente do Estado de São Paulo, 2020). Therefore, São Paulo relies heavily on a massive testing strategy in the attempt to control the epidemic. We simulated two alternative strategies combined with economic evaluations. One strategy included indiscriminately testing the entire population of the State, reaching more than 40 million people at a maximum cost of 2.25 billion USD, that would reduce the total number of cases by the end of 2020 by 90%. The second strategy investigated testing only symptomatic cases and their immediate contactsthis strategy reached a . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101/2020.12.02.20242743 doi: medRxiv preprint 16 maximum cost of 150 million USD but also reduced the number of cases by 90%. As we were interested in the simulation of the impact of testing and quarantining in the spread of the infection in the general population, we did not included testing for other clustering. For instance, health workers are tested regularly in Sao Paulo and are isolated when tested positive. Our model has the following limitations. The model assumes a perfect test with 100% sensitiviy and specificity; we also assumed that tracing the contacts of the positive cases would be perfect, which is obviously a practical impossibility. Another important limitation of the model is that it does not consider any delay in the results of the test, an important factor that has been limiting this strategy in many places of the world (Kretzschmar et al., 2020) . Although the current tests have a delay of many days to present the results, many rapid-molecular point of care tests for detecting positive patients to SARS-CoV-2 are in development (Ahmad et al., 2020) , so the delay in test results can be overcome. However, our model does not take into account social inequity in accessing testing Martins-Filho et al., 2020) . Some strategies could be considered to reduce the testing costs like pooling samples for testing (Abid et al., 2020) or concentrating the tests in neighborhood where sewege systems were tested positive (Foladori et al., 2020) . Had the State of São Paulo decided to adopt this strategy on April the 1 st , it would have been possible to reduce the total number of cases in 90% at a cost of 2.25 billion US dollars for the indiscriminate strategy but at a much smaller cost of 125 million US dollars for the selective testing of symptomatic cases and their contacts. We conclude that a selective test, trace and quarantine strategy is the most cost effective strategy that could be applied in situations where social distancing is difficult to implement. Authors contributions. All authors contributed equally in all phases of this work. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 4, 2020. ; https://doi.org/10.1101 /2020.12.02.20242743 doi: medRxiv preprint Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia Road toward rapidmolecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature The rise in travel-associated measles infections-GeoSentinel Potential for global spread of a novel coronavirus from China Routes for COVID-19 importation in Brazil Expansion of COVID-19 within Brazil: the importance of highways Interface to the Levenberg-Marquardt Nonlinear Least-Squares Algorithm Found in MINPACK, Plus Support for Bounds SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review Severe dengue in travellers: pathogenesis, risk and clinical management Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Importation and early local transmission of COVID-19 in Brazil Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study COVID-19 fatality rates related to social inequality in Northeast Brazil: a neighborhood-level analysis Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre. The case of COVID-19 Painel Coronavírus Serial Interval Distribution of SARS-CoV-2 Infection in Brazil COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation The burden of COVID-19 in Brazil is greater in areas with high social deprivation Ebola virus outbreak in North Kivu and Ituri provinces, Democratic Republic of Congo, and the potential for further transmission through commercial air travel Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak Ethical approval. Not applicable (this is a purely theoretical work with no human subject involved).